CLOs on the Move

Glaukos

www.glaukos.com

 
Glaukos Corporation is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures to transform the treatment of glaucoma, one of the world`s leading causes of blindness. Glaukos has pioneered Micro-Invasive Glaucoma Surgery, or MIGS, to revolutionize the traditional glaucoma treatment and management paradigm. The company launched the iStent Trabecular Micro-Bypass Stent, its first MIGS device, in the United States in 2012. Glaukos is leveraging its platform technology to build a comprehensive and proprietary portfolio of injectable micro-scale therapies designed to address the complete range of glaucoma disease states and progression. Glaukos believes the ...
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.glaukos.com
  • 229 Avenida Fabricante
    San Clemente, CA USA 92672
  • Phone: 949.481.0510

Executives

Name Title Contact Details
Jeffrey Lau
Associate General Counsel Profile
Pamela Nelson
Vice President Regulatory Affairs, Corneal Health Profile
Pamela Nelson
Vice President of Regulatory Affairs, Corneal Health Profile

Similar Companies

Visionix

Visionix is a Blue Bell, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Instromedix dba: LifeWatch

Instromedix dba: LifeWatch is a Des Plaines, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cytrellis

Cytrellis is a medical technology company dedicated to the development and commercialization of first-in-class aesthetic devices which emphasize safety, efficacy, and improved quality of life for our patients. Cytrellis` first product, the ellacor® System with Micro-Coring™ Technology, is indicated for use by medical professionals for the treatment of moderate to severe wrinkles in the mid to lower face in adults aged 22 years or older with Fitzpatrick skin types I-IV. Ellacor provides aesthetic practitioners with an unprecedented ability to improve age-related changes in skin and to help restore youthful beauty.

RenalGuard Solutions

Headquartered in Milford, Massachusetts, RenalGuard Solutions, Inc. is a medical technology company specializing in innovative technologies for the cardiac and vascular markets. Our newest product, RenalGuard®, has been developed to help prevent the onset of contrast-induced nephropathy (CIN) in at-risk patients undergoing certain imaging procedures. It is already approved for sale in the EU for general fluid balancing. Two investigator-sponsored European studies have demonstrated RenalGuard`s effectiveness at preventing CIN. RenalGuard is being studied in a pivotal trial in the U.S., as required for approval by the FDA. The RenalGuard System™ consists of a closed loop, software-controlled console and single-use sets that physicians and nurses use for automated matched fluid replacement to minimize over- or under-hydration of patients during medical procedures where creating and maintaining high urine outputs is beneficial.

Forten Corporation

Forten Corporation is a Poway, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.